Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for sharing…GLTUA!
Long and strong here…GLTUA!
Big, big, big stuff coming. Good to scoop up as much as possible hold for even higher highs than $4+ it hit last time. Im emptying the piggy bank for my retirement play.
Ok so i just saw on CNN money.. looks like they put a buy rating on it, cuz it has a bunch of positive profitable quarters! ????????
It looks like there about to put a possible buy signal on it. But i cant find out why.
That will be fabulous! Fingers crossed.
Yeah, maybe it'll keep goin
Cool, thanks. Hopefully we’ll find out soon if anything is in the pipeline.
I have no idea, but i aint mad at it.
Any idea what going on here and why the uptick?
The Company is currently undergoing a strategic review of its operations.
BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty, food and beverage industry. The Company is currently undergoing a strategic review of its operations.
anyone know why this would jump .0643 on volume of 400 shares
$BLFE BioLife Sciences Inc. (OTCPK:BLFE) Announces the Launch of Their New Copper Infused Face Masks
Press Release | 02/26/2021
Toronto, Ontario, Canada, Feb. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences (OTCPK: BLFE) announces the launch of their Copper-Infused Face Masks to provide consumers with the long-lasting health and protective benefits of antimicrobial copper, which is infused throughout the fabric using NanoFusion Technology. NanoFusion Technology leverages the natural antimicrobial benefits of copper ions, which have been shown to kill 99.99% of bacteria, fungi and viruses. Historically copper has been utilized for its ability to eliminate bad smelling odors and purify drinking water.
Unlike other products incorporating copper yarns into a small portion of the overall fabric, NanoFusion Technology infuses copper metal ions into every sub-fiber of the fabrics. This results in superior copper coverage, providing continuous protection of the fabric against germs which can live on the mask for days. Copper, in various forms, has been demonstrated to inactivate bacteria and viruses within hours. In addition, numerous studies have shown copper to provide multiple health benefits to the skin, including anti-inflammatory and regenerative properties.
The face masks are available in cotton and polyester blends in wholesale quantities and are 100% manufactured in North America.
About BioLife Sciences Inc.
BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption. Its core business develops, licenses and distributes antimicrobial products, non-contact human temperature screening technology, and touchless vending/marketplaces. One of BioLife Sciences’ core building block strategies is to develop, partner and assist innovative companies with the commercialization of leading-edge technologies.
Disclaimer
The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to, the ability of the Corporation to complete a qualifying transaction. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurance that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.
Media Relations
+18339191037
I think that its just on their board shake up. I think that this is going to bounce back.
This stock based on it’s products and board look promising. Any idea why the stock price keeps falling?
I think that this is going to recover nicely
$BLFE OTC Pink
$BLFE $.001 tomorrow
OH, This a 10.00 stock were is your faith- ha ha
OH, This a 10.00 stock were is your faith- ha ha
I'm new to this stock, so I only bought 500 shares, but I'm a rideshare driver and we have a BioLife building, quite a large one, in a town of 60,000, and it's always Very Busy.........
We're a university town, and students are constantly selling their plasma. Yesterday, was a mind blower, as one college girl said she just got over covid a very short time ago, having only one minor symptom, lose of smell. I couldn't believe at first, they would take her blood, but she informed me they wanted her plasma, as they pull out anti-gens, or whatever to give to patients who are in dangerous trouble.
She's receiving 200.00, so I just realized the value of a healthy college student, who had a mild case, had such value with her plasma.
It may be a penny stock, but the company is doing very well in Wiscosin.
$BLFE BioLife Sciences (OTCPK:BLFE) Initiates Process for Up-Listing to OTCQB
Press Release | 11/09/2020
TORONTO, ONTARIO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTCPK:BLFE) announces it has initiated the process of up-listing to the Over the Counter Quotation Bureau (“OTCQB®”) by engaging MNP LLP (“MNP”), an accounting firm registered with the U.S Public Company Accounting Oversighting Board (“PCAOB”), to independently audit BioLife’s finances. MNP is one of Canada's largest national accounting and business consulting firms.
MNP will conduct their audit in accordance with the standards established by the Public Company Accounting Oversight Board (PCAOB) (United States) and will include tests of the Company’s accounting records and other procedures. Upon completion of the auditing, MNP will submit to the audit committee a report with MNP’s opinion on the consolidated financial statements of BioLife.
MNP will examine the consolidated statement of financial position of BioLife as of November 30, 2020; November 30, 2019; and December 1, 2018.
BioLife considers this action to be fundamental and necessary to the company’s efforts to demonstrate greater transparency to its investors and as such, to bring greater visibility to investor groups seeking to commit towards longer-term investments with BioLife. To be eligible to trade on this market tier, companies must be current in their financial reporting, pass a minimum bid price test and undergo an annual company verification and management certification process.
The OTCQB® Venture Market will allow the company to appeal to a more sophisticated pool of investors, particularly to institutional investors, dramatically increase liquidity and visibility, as well as solidify their position within the commercialization market.
About BioLife Sciences Inc.
BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption. Its core business develops, licenses and distributes antimicrobial products, non-contact human temperature screening technology, and touchless vending/marketplaces. One of BioLife Sciences’ core building block strategies is to develop, partner and assist innovative companies with the commercialization of leading-edge technologies.
About MNP LLP
MNP is a leading national accounting, tax and business consulting firm in Canada. They proudly serve and respond to the needs of their clients in the public, private and not-for-profit sectors. Through partner-led engagements, they provide a collaborative, cost-effective approach to doing business and personalized strategies to help organizations succeed across the country and around the world. For more information, visit www.mnp.ca.
Contact Information:
www.biolifesciences.com
ir@biolifesciences.com
US: (775) 981-0270
Canada: (647) 558-6663
Disclaimer
The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward-looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Forward-looking statements in this news release include, but are not limited to, the ability of the Corporation to complete a qualifying transaction. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurance that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.
$BLFE BioLife Sciences (OTCPK: BLFE) to Receive $4.5M USD Strategic Investment From BeMotion Inc. to Expand and Accelerate Commercialization of Non-Contact Smart Vending Technology
Press Release | 11/05/2020
Toronto, Ontario, Canada, Nov. 05, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences Inc. (OTCPK: BLFE) is pleased to announce it has reached an agreement with BeMotion Inc. for strategic investment to accelerate the commercialization of its advanced smart digital vending platform. BeMotion will invest a total of $4.5M USD as a combination of services and capital equipment into BioLife Sciences to fulfill and expand their current contracts.
This investment represents a significant step towards BioLife and BeMotion realizing a shared vision of smart digital vending which provides a solution to last-mile product distribution in the rapidly shifting landscape of retail which is re-shaping where and how consumers purchase products.
“We are excited to deepen our relationship with BeMotion on their next-generation vending platforms. It is clear to us that BeMotion has the most advanced vending technology in the world in addition to the IT expertise necessary to exploit the M-Commerce and Digital marketing capabilities. The platform is very dynamic which will allow us to expand this solution into new markets across North America.” – said Mr. DeFour, CEO of BioLife Sciences.
The DCN Vending and Marketplace platform allows users to interact with the machines without contact through their smartphone and boasts a staggering array of features that benefit retailers such as M-Commerce, Products Directory, Loyalty Program, Delivery, Digital Advertising and Detailed Analytics.
“We believe that smart vending is the future of retail. BioLife’s unique position within food & beverage markets combined with their strategic distribution relationships within the Canadian market made our choice to partner with BioLife very easy.” – said Mr. Abu Hassan, CEO of BeMotion Inc.
BioLife Sciences plans to roll-out the systems throughout their existing distribution network with the initial targets being transit hubs across Canada.
About BioLife Sciences Inc.
BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption. Its core business develops, licenses and distributes antimicrobial products, non-contact human temperature screening technology, and touchless vending/marketplaces. One of BioLife Sciences’ core building block strategies is to develop, partner and assist innovative companies with the commercialization of leading-edge technologies.
About BeMotion Inc. www.bemotioninc.com / DCN Vending & Marketplace. www.dcnvending.com
BeMotion Inc. provides a complete technological & strategic solution that taps into the next generation of digital opportunities. Established in 2016, BeMotion Inc. has developed and launched the MCN Platform with state-of-the-art thermal scanners. BeMotion Inc. is a privately-owned company with offices in Toronto, Dubai and London.
Disclaimer
The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward-looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Forward-looking statements in this news release include, but are not limited to, the ability of the Corporation to complete a qualifying transaction. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurance that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.
Media Relations
775-981-0270
ir@biolifesciences.com
That’s why I didn’t even waste my time to respond. I think someone is trying to scare weak hands to sell so he/she can grab.
It a very low floater so it goes up and down very fast
It has nothing to do with a scam some people have nothing better to do
Why, because it’s literally a scam? I thought so.
lol
yea, that was a great recovery, it should keep going. Even though the company is a penny stock and they arent reporting any income, but theyre also in the business of production. ????
That makes me feel way better!!!
Man, I hope I’m excluded but if not all I have to say is I hope you know a pumper when you see one. I invested in this thing about a decade ago, been holding since, been through three or four symbol changes and two R/S that I can remember so I’m not a pumper my friend. Even though it’s dropped significantly I’m still on the upside, I just hope it stops and bounces back. Fingers crossed!
You guys need to get out while you can! I’m literally trying to save people who are holding the bag haha
The market cap is close to 100 million and they have no assets or revenues!
Run by the same scammers pumping CLOW right now and previously pumped DKMR, DEVV, PTCO
Look how those ended up. You can thank me later :)
Followers
|
128
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
8554
|
Created
|
05/14/07
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |